Invenomic Capital Management’s Citigroup C Stock Holding History

Invenomic Capital Management’s Portfolio C Stock Details C Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-577,068	Closed	-$29.7M	–	153
2023 Q4	$29.7M	Sell	577,068 -882,377	-60%	-$39.1M	1.35%	20
2023 Q3	$60M	Buy	1,459,445 +862,628	+145%	+$37.9M	2.52%	4
2023 Q2	$27.5M	Buy	+596,817	New	+$28M	1.39%	21
2021 Q3	–	Sell	-14,108	Closed	-$998K	–	124
2021 Q2	$998K	Sell	14,108 -7,712	-35%	-$571K	0.24%	82
2021 Q1	$1.59M	Sell	21,820 -2,568	-11%	-$171K	0.35%	57
2020 Q4	$1.5M	Sell	24,388 -125	-0.5%	-$6.35K	0.38%	56
2020 Q3	$1.06M	Buy	24,513 +11,136	+83%	+$555K	0.58%	54
2020 Q2	$684K	Buy	+13,377	New	+$635K	0.51%	68

Other funds holding C

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invenomic Capital Management's C Position: Q1 2024 in Review

Invenomic Capital Management sold out of Citigroup (C) in Q1 2024, closing a stake of 577,068 shares — an estimated $29.7M sold.

Invenomic Capital Management first reported a position in C in Q2 2020 and held it in 8 quarters. The position peaked at $60M in Q3 2023. 1,774 funds tracked by Wall St. Rank hold C as of Q1 2024.

Invenomic Capital Management reported no remaining Citigroup position as of Q1 2024 after selling out during the quarter.
Invenomic Capital Management sold 577,068 Citigroup shares in Q1 2024, an estimated $29.7M.
Invenomic Capital Management first reported a position in Citigroup in Q2 2020 and held it in 8 quarters.
Invenomic Capital Management's Citigroup position peaked at $60M in Q3 2023.
1,774 funds tracked by Wall St. Rank held Citigroup as of Q1 2024.

Based on Invenomic Capital Management's 13F filing for Q1 2024, filed 15 May 2024.